BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18538016)

  • 1. Bacterial-based systems for expression and purification of recombinant Lassa virus proteins of immunological relevance.
    Branco LM; Matschiner A; Fair JN; Goba A; Sampey DB; Ferro PJ; Cashman KA; Schoepp RJ; Tesh RB; Bausch DG; Garry RF; Guttieri MC
    Virol J; 2008 Jun; 5():74. PubMed ID: 18538016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncoupling GP1 and GP2 expression in the Lassa virus glycoprotein complex: implications for GP1 ectodomain shedding.
    Illick MM; Branco LM; Fair JN; Illick KA; Matschiner A; Schoepp R; Garry RF; Guttieri MC
    Virol J; 2008 Dec; 5():161. PubMed ID: 19105844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever.
    Branco LM; Grove JN; Geske FJ; Boisen ML; Muncy IJ; Magliato SA; Henderson LA; Schoepp RJ; Cashman KA; Hensley LE; Garry RF
    Virol J; 2010 Oct; 7():279. PubMed ID: 20961433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects.
    Branco LM; Grove JN; Moses LM; Goba A; Fullah M; Momoh M; Schoepp RJ; Bausch DG; Garry RF
    Virol J; 2010 Nov; 7():306. PubMed ID: 21062490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits.
    Robinson JE; Hastie KM; Cross RW; Yenni RE; Elliott DH; Rouelle JA; Kannadka CB; Smira AA; Garry CE; Bradley BT; Yu H; Shaffer JG; Boisen ML; Hartnett JN; Zandonatti MA; Rowland MM; Heinrich ML; Martínez-Sobrido L; Cheng B; de la Torre JC; Andersen KG; Goba A; Momoh M; Fullah M; Gbakie M; Kanneh L; Koroma VJ; Fonnie R; Jalloh SC; Kargbo B; Vandi MA; Gbetuwa M; Ikponmwosa O; Asogun DA; Okokhere PO; Follarin OA; Schieffelin JS; Pitts KR; Geisbert JB; Kulakoski PC; Wilson RB; Happi CT; Sabeti PC; Gevao SM; Khan SH; Grant DS; Geisbert TW; Saphire EO; Branco LM; Garry RF
    Nat Commun; 2016 May; 7():11544. PubMed ID: 27161536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic diversity among Lassa virus strains.
    Bowen MD; Rollin PE; Ksiazek TG; Hustad HL; Bausch DG; Demby AH; Bajani MD; Peters CJ; Nichol ST
    J Virol; 2000 Aug; 74(15):6992-7004. PubMed ID: 10888638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the Lassa virus GP1 ectodomain shedding: implications for improved diagnostic platforms.
    Branco LM; Garry RF
    Virol J; 2009 Sep; 6():147. PubMed ID: 19778448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-Molecule Fusion Inhibitors Bind the pH-Sensing Stable Signal Peptide-GP2 Subunit Interface of the Lassa Virus Envelope Glycoprotein.
    Shankar S; Whitby LR; Casquilho-Gray HE; York J; Boger DL; Nunberg JH
    J Virol; 2016 Aug; 90(15):6799-807. PubMed ID: 27194767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of recombinant nucleoprotein-based diagnostic systems for Lassa fever.
    Saijo M; Georges-Courbot MC; Marianneau P; Romanowski V; Fukushi S; Mizutani T; Georges AJ; Kurata T; Kurane I; Morikawa S
    Clin Vaccine Immunol; 2007 Sep; 14(9):1182-9. PubMed ID: 17634509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Old and New World arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clones.
    Meulen Jt; Badusche M; Satoguina J; Strecker T; Lenz O; Loeliger C; Sakho M; Koulemou K; Koivogui L; Hoerauf A
    Virology; 2004 Mar; 321(1):134-43. PubMed ID: 15033572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological Characterization of Conserved Residues within the Cytoplasmic Tail of the Pichinde Arenaviral Glycoprotein Subunit 2 (GP2).
    Shao J; Huang Q; Liu X; Di D; Dileepan M; Brisse M; Ly H; Liang Y
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational Analysis of Lassa Virus Glycoprotein Highlights Regions Required for Alpha-Dystroglycan Utilization.
    Acciani M; Alston JT; Zhao G; Reynolds H; Ali AM; Xu B; Brindley MA
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28679759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs.
    Jiang X; Dalebout TJ; Bredenbeek PJ; Carrion R; Brasky K; Patterson J; Goicochea M; Bryant J; Salvato MS; Lukashevich IS
    Vaccine; 2011 Feb; 29(6):1248-57. PubMed ID: 21145373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assays to Assess Arenaviral Glycoprotein Function.
    Shao J; Liu X; Liang Y; Ly H
    Methods Mol Biol; 2018; 1604():169-178. PubMed ID: 28986832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lassa virus glycoprotein complex review: insights into its unique fusion machinery.
    Pennington HN; Lee J
    Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35088070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies.
    Ruo SL; Mitchell SW; Kiley MP; Roumillat LF; Fisher-Hoch SP; McCormick JB
    J Gen Virol; 1991 Mar; 72 ( Pt 3)():549-55. PubMed ID: 1706408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antifungal isavuconazole inhibits the entry of lassa virus by targeting the stable signal peptide-GP2 subunit interface of lassa virus glycoprotein.
    Zhang X; Tang K; Guo Y
    Antiviral Res; 2020 Feb; 174():104701. PubMed ID: 31877348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidation-sensitive polymersomes as vaccine nanocarriers enhance humoral responses against Lassa virus envelope glycoprotein.
    Galan-Navarro C; Rincon-Restrepo M; Zimmer G; Ollmann Saphire E; Hubbell JA; Hirosue S; Swartz MA; Kunz S
    Virology; 2017 Dec; 512():161-171. PubMed ID: 28963882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of recombinant lymphocytic choriomeningitis virus/Lassa virus in vivo highlights the importance of the GPC cytosolic tail in viral fitness.
    Sommerstein R; Ramos da Palma J; Olschläger S; Bergthaler A; Barba L; Lee BP; Pasquato A; Flatz L
    J Virol; 2014 Aug; 88(15):8340-8. PubMed ID: 24829355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamp1 Increases the Efficiency of Lassa Virus Infection by Promoting Fusion in Less Acidic Endosomal Compartments.
    Hulseberg CE; Fénéant L; Szymańska KM; White JM
    mBio; 2018 Jan; 9(1):. PubMed ID: 29295909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.